IVLU - AI Analysis

Compare

Top Page

iShares MSCI Intl Value Factor ETF (IVLU)

Rating:66Neutral

Price Target:

$38.00

The iShares MSCI Intl Value Factor ETF (IVLU) benefits from strong contributions by holdings like HSBC and Toyota Motor, which showcase robust financial performance, attractive valuations, and positive growth initiatives. However, weaker holdings such as Banco Santander and BNP Paribas, with bearish technical indicators and challenges in revenue growth, slightly weigh on the fund’s overall rating. The ETF's main risk lies in its exposure to financial stocks, which could be sensitive to market volatility and economic conditions.

Positive Factors

Strong Top Holdings

Several key holdings, such as Banco Santander and British American Tobacco, have delivered strong year-to-date performance, supporting the ETF’s overall returns.

Global Diversification

The ETF provides exposure to a wide range of countries, including Japan, the UK, and Germany, reducing reliance on any single market.

Reasonable Expense Ratio

With a 0.3% expense ratio, the fund offers a cost-effective way to invest in international value stocks compared to many actively managed alternatives.

Negative Factors

Underperforming Holdings

Some top holdings, like Toyota Motor, have shown weak year-to-date performance, which could drag on the fund’s overall returns.

Sector Concentration in Financials

The ETF has a heavy allocation to financial stocks, which could make it vulnerable to sector-specific risks.

Limited U.S. Exposure

With only 6% of the fund invested in U.S. companies, it may miss out on opportunities in the world’s largest economy.

IVLU vs. SPDR S&P 500 ETF (SPY)

AUM2.74B

RegionDeveloped Markets

Expense Ratio0.30%

Beta0.68

IssueriShares

Inception DateJun 16, 2015

Dividend Yield3.55%

Asset ClassEquity

Index TrackedMSCI World ex USA Enhanced Value

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume543,508

30 Day Avg. Volume579,778

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

40.01

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering344

IVLU Summary

The iShares MSCI Intl Value Factor ETF (IVLU) is an investment fund that focuses on undervalued stocks in developed markets outside the U.S., following the MSCI World ex USA Enhanced Value Index. It includes well-known companies like Toyota Motor and British American Tobacco, and offers exposure to industries such as financials and healthcare. This ETF can be a good choice for investors looking to diversify internationally and invest in stocks with potential for growth based on value metrics. However, new investors should be aware that its performance depends on global markets, which can be volatile and impacted by economic changes worldwide.

How much will it cost me?The iShares MSCI Intl Value Factor ETF (IVLU) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it focuses on a specific strategy of selecting undervalued international stocks, which requires more research and analysis.

What would affect this ETF?The iShares MSCI Intl Value Factor ETF (IVLU) could benefit from a global economic recovery, especially in developed markets outside the U.S., as undervalued stocks in sectors like financials and industrials may see growth. However, challenges such as rising interest rates or geopolitical tensions in key regions could negatively impact its holdings, particularly in sectors like energy and consumer cyclical. The ETF’s focus on value stocks provides diversification but may underperform during periods where growth stocks dominate market trends.

IVLU Top 10 Holdings

The iShares MSCI Intl Value Factor ETF (IVLU) leans heavily into financials and industrials, with names like HSBC and Siemens driving steady performance thanks to strong profitability and strategic growth initiatives. Health care stocks such as Roche and Novartis add resilience, benefiting from robust pipelines and effective cash flow management. However, British American Tobacco and BNP Paribas are lagging, with bearish trends and revenue challenges holding them back. With its focus on developed markets outside the U.S., IVLU offers a diversified play on undervalued global equities, though some holdings face headwinds that could temper near-term gains.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HSBA	HSBC Holdings	2.32%	$63.17M	£182.93B	49.86%	79 Outperform
BATS	British American Tobacco	2.29%	$62.38M	£84.99B	44.32%	60 Neutral
7203	Toyota Motor	2.16%	$58.91M	¥40.90T	19.98%	81 Outperform
SAN	Banco Santander	1.98%	$53.99M	€131.13B	99.74%	66 Neutral
NOVN	Novartis AG	1.68%	$45.95M	CHF188.93B	3.96%	78 Outperform
SIE	Siemens	1.56%	$42.55M	€192.31B	37.05%	74 Outperform
ROG	Roche Holding AG	1.53%	$41.65M	CHF207.54B	3.75%	73 Outperform
SHEL	Shell (UK)	1.41%	$38.50M	£163.89B	10.41%	77 Outperform
SAN	Sanofi	1.41%	$38.37M	€106.80B	-7.30%	77 Outperform
BARC	Barclays	1.22%	$33.34M	£56.60B	69.16%	77 Outperform

IVLU Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

35.48

Positive

100DMA

34.43

Positive

200DMA

32.08

Positive

Market Momentum

MACD

0.19

Negative

RSI

56.62

Neutral

STOCH

56.45

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IVLU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.67, equal to the 50-day MA of 35.48, and equal to the 200-day MA of 32.08, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 56.62 is Neutral, neither overbought nor oversold. The STOCH value of 56.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IVLU.

IVLU Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IVLU	―	―	$2.74B	0.30%	66 Neutral
GSIE	―	―	$4.63B	0.25%	65 Neutral
IMTM	―	―	$3.43B	0.30%	67 Neutral
LVHI	―	―	$3.42B	0.40%	69 Neutral
INTF	―	―	$2.71B	0.16%	64 Neutral
PXF	―	―	$2.16B	0.43%	62 Neutral

Performance Comparison

IVLU

iShares MSCI Intl Value Factor ETF

35.97

8.70

31.90%

GSIE

Goldman Sachs ActiveBeta International Equity ETF

―

IMTM

iShares MSCI Intl Momentum Factor ETF

―

LVHI

Legg Mason International Low Volatility High Dividend ETF

―

INTF

iShares MSCI Intl Multifactor ETF

―

PXF

Invesco FTSE RAFI Developed Markets ex-U.S. ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents